Found: 25
Select item for more details and to access through your institution.
Relationship of the urine cortisol level with the performance status of patients with lung cancer: a retrospective study.
- Published in:
- Supportive Care in Cancer, 2015, v. 23, n. 7, p. 2129, doi. 10.1007/s00520-014-2585-5
- By:
- Publication type:
- Article
Pure Red Cell Aplasia and Chromosomal Abnormality in a Patient With Lung Adenocarcinoma Receiving Immune Checkpoint Inhibitors: A Case Report.
- Published in:
- In Vivo, 2024, v. 38, n. 3, p. 1509, doi. 10.21873/invivo.13599
- By:
- Publication type:
- Article
Case Series of Pleomorphic Carcinoma of the Lung Treated With Immune Checkpoint Inhibitors.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
SIRT1 and FOXO1 mRNA expression in PBMC correlates to physical activity in COPD patients.
- Published in:
- International Journal of COPD, 2017, v. 12, p. 3237, doi. 10.2147/COPD.S144969
- By:
- Publication type:
- Article
Systemic dissemination of chronic necrotizing pulmonary aspergillosis in an elderly woman without comorbidity: a case report.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Miliary brain metastasis presenting with calcification in a patient with lung cancer: a case report.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Relationship between Carnitine Pharmacokinetics and Fatigue in Patients Treated with Cisplatin-Containing Chemotherapy.
- Published in:
- Oncology Research & Treatment, 2017, v. 40, n. 1/2, p. 42, doi. 10.1159/000455255
- By:
- Publication type:
- Article
Utility of creatinine/cystatin C ratio as a predictive marker for adverse effects of chemotherapy in lung cancer: A retrospective study.
- Published in:
- Journal of International Medical Research, 2015, v. 43, n. 4, p. 573, doi. 10.1177/0300060515579116
- By:
- Publication type:
- Article
Clinical Parameters for Predicting the Survival in Patients with Squamous and Non-squamous-cell NSCLC Receiving PD-1 Inhibitor Therapy.
- Published in:
- Pathology & Oncology Research, 2020, v. 26, n. 1, p. 327, doi. 10.1007/s12253-018-0473-x
- By:
- Publication type:
- Article
Elevated levels of plasma lactate dehydrogenase is an unfavorable prognostic factor in patients with epidermal growth factor receptor mutation-positive non-small cell lung cancer, receiving treatment with gefitinib or erlotinib.
- Published in:
- Molecular & Clinical Oncology, 2016, v. 4, n. 5, p. 774, doi. 10.3892/mco.2016.779
- By:
- Publication type:
- Article
Plasma neuron-specific enolase level as a prognostic marker in patients with non-small cell lung cancer receiving gefitinib.
- Published in:
- Molecular & Clinical Oncology, 2015, v. 3, n. 4, p. 62, doi. 10.3892/mco.2015.568
- By:
- Publication type:
- Article
Efficacy of immune checkpoint inhibitor therapy in patients with pulmonary sarcomatoid carcinoma in clinical practice.
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 17, p. 1618, doi. 10.1111/1759-7714.14907
- By:
- Publication type:
- Article
Visceral adipose tissue level, as estimated by the bioimpedance analysis method, is associated with impaired lung function.
- Published in:
- Journal of Diabetes Investigation, 2012, v. 3, n. 3, p. 331, doi. 10.1111/j.2040-1124.2011.00189.x
- By:
- Publication type:
- Article
Thymoma with Autoimmune Hemolytic Anemia.
- Published in:
- Case Reports in Oncology, 2014, v. 7, n. 3, p. 764, doi. 10.1159/000369491
- By:
- Publication type:
- Article
Sirtuin 1 activator SRT1720 suppresses inflammation in an ovalbumin-induced mouse model of asthma.
- Published in:
- Respirology, 2013, v. 18, n. 2, p. 332, doi. 10.1111/j.1440-1843.2012.02284.x
- By:
- Publication type:
- Article
Association of Tumor PD-L1 Expression with the T790M Mutation and Progression-Free Survival in Patients with EGFR-Mutant Non-Small Cell Lung Cancer Receiving EGFR-TKI Therapy.
- Published in:
- Diagnostics (2075-4418), 2020, v. 10, n. 12, p. 1006, doi. 10.3390/diagnostics10121006
- By:
- Publication type:
- Article
Real-World Data on Subsequent Therapy for First-Line Osimertinib-Induced Pneumonitis: Safety of EGFR-TKI Rechallenge (Osi-risk Study TORG-TG2101).
- Published in:
- Targeted Oncology, 2024, v. 19, n. 3, p. 423, doi. 10.1007/s11523-024-01048-x
- By:
- Publication type:
- Article
Association of serum adiponectin with asthma and pulmonary function in the Japanese population.
- Published in:
- Endocrine Journal, 2015, v. 62, n. 8, p. 695, doi. 10.1507/endocrj.ej14-0626
- By:
- Publication type:
- Article
Comparing the Effectiveness of Afatinib and Osimertinib for Patients With PD-L1-positive EGFR-mutant Non-small Cell Carcinoma.
- Published in:
- Cancer Diagnosis & Prognosis, 2024, v. 4, n. 4, p. 515, doi. 10.21873/cdp.10357
- By:
- Publication type:
- Article
A retrospective study of the efficacy of combined EGFR-TKI plus VEGF inhibitor/cytotoxic therapy vs. EGFR-TKI monotherapy for PD-L1-positive EGFR-mutant non-small cell lung cancer: North Japan Lung Cancer Study Group 2202.
- Published in:
- Oncology Letters, 2023, v. 26, n. 2, p. 1, doi. 10.3892/ol.2023.13920
- By:
- Publication type:
- Article
Comparison of the efficacy of first‑/second‑generation EGFR‑tyrosine kinase inhibitors and osimertinib for EGFR‑mutant lung cancer with negative or low PD‑L1 expression.
- Published in:
- Molecular & Clinical Oncology, 2024, v. 20, n. 6, p. N.PAG, doi. 10.3892/mco.2024.2741
- By:
- Publication type:
- Article
Associations of immune checkpoint inhibitor therapy efficacy with clinical parameters and tumor‑infiltrating CD68‑positive cell counts in patients with EGFR‑mutant non‑small cell lung cancer.
- Published in:
- Molecular & Clinical Oncology, 2023, v. 18, n. 5, p. N.PAG, doi. 10.3892/mco.2023.2634
- By:
- Publication type:
- Article
Clinical Course After Initiation of Nivolumab Therapy in Patients with EGFR-Mutated Non-Small Cell Lung Cancer With or Without Pd-L1 Expression.
- Published in:
- Oncology & Therapy, 2017, v. 5, n. 2, p. 181, doi. 10.1007/s40487-017-0053-3
- By:
- Publication type:
- Article
Peripheral CD4 memory T cells predict the efficacy of immune checkpoint inhibitor therapy in patients with non-small cell lung cancer.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-37736-3
- By:
- Publication type:
- Article
Usefulness of the Palliative Prognostic Index in patients with lung cancer.
- Published in:
- Medical Oncology, 2014, v. 31, n. 9, p. 1, doi. 10.1007/s12032-014-0154-x
- By:
- Publication type:
- Article